Marstacimab for treating severe haemophilia A or severe haemophilia B in people 12 years and over [ID6342] Draft guidance Technology appraisal guidance 6 February 2025 Capivasertib with fulvestrant ...
NICE, in collaboration with other international health technology assessment agencies, has published a new report which ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback